Name | Number of supported studies | Average coverage | |
---|---|---|---|
mesothelial cell | 12 studies | 53% ± 17% | |
type I pneumocyte | 10 studies | 44% ± 18% | |
type II pneumocyte | 7 studies | 21% ± 4% | |
respiratory goblet cell | 6 studies | 33% ± 7% | |
secretory cell | 5 studies | 46% ± 29% | |
epithelial cell | 5 studies | 31% ± 12% | |
club cell | 4 studies | 33% ± 12% | |
deuterosomal cell | 4 studies | 32% ± 11% | |
duct epithelial cell | 3 studies | 27% ± 16% | |
ciliated cell | 3 studies | 20% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 5915.51 | 577 / 578 | 46% | 320.54 | 534 / 1155 |
ovary | 42% | 333.96 | 75 / 180 | 97% | 1025.39 | 419 / 430 |
uterus | 81% | 773.29 | 138 / 170 | 47% | 220.19 | 214 / 459 |
stomach | 65% | 189.57 | 235 / 359 | 49% | 103.77 | 140 / 286 |
kidney | 93% | 533.93 | 83 / 89 | 18% | 45.08 | 164 / 901 |
intestine | 42% | 166.39 | 408 / 966 | 53% | 127.55 | 278 / 527 |
pancreas | 15% | 33.41 | 49 / 328 | 80% | 399.77 | 142 / 178 |
prostate | 57% | 358.12 | 140 / 245 | 1% | 0.93 | 6 / 502 |
esophagus | 28% | 214.11 | 411 / 1445 | 30% | 68.45 | 54 / 183 |
adipose | 42% | 3981.23 | 506 / 1204 | 0% | 0 | 0 / 0 |
skin | 41% | 69.50 | 748 / 1809 | 0% | 0.17 | 1 / 472 |
bladder | 10% | 41.67 | 2 / 21 | 22% | 72.64 | 111 / 504 |
tonsil | 0% | 0 | 0 / 0 | 29% | 47.82 | 13 / 45 |
breast | 18% | 38.11 | 83 / 459 | 10% | 33.78 | 111 / 1118 |
brain | 27% | 37.81 | 706 / 2642 | 0% | 0.19 | 3 / 705 |
heart | 21% | 313.67 | 185 / 861 | 0% | 0 | 0 / 0 |
spleen | 9% | 15.77 | 22 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 8% | 61.74 | 103 / 1335 | 0% | 0 | 0 / 0 |
thymus | 5% | 11.24 | 35 / 653 | 2% | 15.73 | 14 / 605 |
peripheral blood | 6% | 29.46 | 55 / 929 | 0% | 0 | 0 / 0 |
liver | 1% | 1.12 | 2 / 226 | 1% | 7.15 | 6 / 406 |
adrenal gland | 2% | 2.55 | 5 / 258 | 0% | 0 | 0 / 230 |
muscle | 0% | 0.33 | 2 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007155 | Biological process | cell adhesion |
GO_0007160 | Biological process | cell-matrix adhesion |
GO_0009986 | Cellular component | cell surface |
GO_0098552 | Cellular component | side of membrane |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005576 | Cellular component | extracellular region |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | MSLN |
Protein name | Mesothelin Mesothelin (CAK1 antigen) (Pre-pro-megakaryocyte-potentiating factor) [Cleaved into: Megakaryocyte-potentiating factor (MPF); Mesothelin, cleaved form] |
Synonyms | MPF |
Description | FUNCTION: Membrane-anchored forms may play a role in cellular adhesion.; FUNCTION: Megakaryocyte-potentiating factor (MPF) potentiates megakaryocyte colony formation in vitro. |
Accessions | ENST00000566269.6 ENST00000566549.5 [Q13421-3] H3BMA1 ENST00000545450.7 [Q13421-3] ENST00000563651.5 H3BR90 H3BV92 H3BUX1 Q13421 ENST00000561896.1 ENST00000563941.5 [Q13421-3] ENST00000382862.7 [Q13421-1] ENST00000569566.2 |